XNYS · Healthcare · Medical Instruments & Supplies
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q2 2026 | 2.77 | 2.90 | +4.69% | $4.71B | ✅ Beat | +3.27% | -5.74% | — |
| 2026-02-09 | Q1 2026 | 2.82 | 2.91 | +3.19% | $5.25B | ✅ Beat | -0.48% | -14.47% | -21.32% |
| 2025-11-06 |
| Q4 2025 |
| 3.91 |
| 3.96 |
| +1.28% |
| $5.89B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-07 | Q3 2025 | 3.41 | 3.68 | +7.92% | $5.51B | ✅ Beat | — | — | — |
| 2025-05-01 | Q2 2025 | 3.28 | 3.35 | +2.13% | $5.27B | ✅ Beat | -0.45% | -0.94% | -0.08% |
| 2025-02-05 | Q1 2025 | 2.99 | 3.43 | +14.72% | $5.17B | ✅ Beat | -7.28% | -7.84% | -6.33% |
| 2024-11-07 | Q4 2024 | 3.77 | 3.81 | +1.06% | $5.44B | ✅ Beat | +1.99% | +0.03% | -1.81% |
| 2024-08-01 | Q3 2024 | 3.31 | 3.50 | +5.74% | $4.99B | ✅ Beat | +2.48% | -0.69% | +2.61% |
Showing last 8 quarters.